|
1
|
Ma S, Chan KW and Guan XY: In search of
liver cancer stem cells. Stem Cell Rev. 4:179–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tomuleasa C, Soritau O, Rus-Ciuca D, Pop
T, Todea D, Mosteanu O, Pintea B, Foris V, Susman S, Kacsó G, et
al: Isolation and characterization of hepatic cancer cells with
stem-like properties from hepatocellular carcinoma. J
Gastrointestin Liver Dis. 19:61–67. 2010.PubMed/NCBI
|
|
3
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:1111152007. View Article : Google Scholar
|
|
4
|
Lee TK, Castilho A, Ma S and Ng IO: Liver
cancer stem cells: Implications for a new therapeutic target. Liver
Int. 29:955–965. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mackillop WJ, Ciampi A, Till JE and Buick
RN: A stem cell model of human tumor growth: Implications for tumor
cell clonogenic assays. J Natl Cancer Inst. 70:9–16.
1983.PubMed/NCBI
|
|
6
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: Mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Curry SC, Carlton MW and Raschke RA:
Prevention of fetal and maternal cyanide toxicity from
nitroprusside with coinfusion of sodium thiosulfate in gravid ewes.
Anesth Analg. 84:1121–1126. 1997.PubMed/NCBI
|
|
9
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clarke PR, Hoffmann I, Draetta G and
Karsenti E: Dephosphorylation of cdc25-C by a type-2A protein
phosphatase: Specific regulation during the cell cycle in Xenopus
egg extracts. Mol Biol Cell. 4:397–411. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen YN, Chen JC, Yin SC, Wang GS, Tsauer
W, Hsu SF and Hsu SL: Effector mechanisms of norcantharidin-induced
mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer.
100:158–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK,
Kuo YS, Chiang CP and Kuo MY: Norcantharidin-induced apoptosis in
oral cancer cells is associated with an increase of proapoptotic to
antiapoptotic protein ratio. Cancer Lett. 217:43–52. 2005.
View Article : Google Scholar
|
|
13
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Williams LA, Möller W, Merisor E, Kraus W
and Rösner H: In vitro anti-proliferation/cytotoxic activity of
cantharidin (Spanish Fly) and related derivatives. West Indian Med
J. 52:10–13. 2003.PubMed/NCBI
|
|
15
|
Yi SN, Wass J, Vincent P and Iland H:
Inhibitory effect of norcantharidin on K562 human myeloid leukemia
cells in vitro. Leuk Res. 15:883–886. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naujokat C and Steinhart R: Salinomycin as
a drug for targeting human cancer stem cells. J Biomed Biotechnol.
2012:9506582012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Li Y, Ahmad A, Azmi AS, Kong D,
Banerjee S and Sarkar FH: Targeting miRNAs involved in cancer stem
cell and EMT regulation: An emerging concept in overcoming drug
resistance. Drug Resist Updat. 13:109–118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu J, Kopecková P, Bühler P, Wolf P, Pan
H, Bauer H, Elsässer-Beile U and Kopeček J: Biorecognition and
subcellular trafficking of HPMA copolymeranti PSMA antibody
conjugates by prostate cancer cells. Mol Pharm. 6:9599702009.
View Article : Google Scholar
|
|
19
|
Mizrak D, Brittan M and Alison M: CD133:
Molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar
|
|
20
|
Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y,
Tan J, Cao Y, Tsao SW, Srivastava G, et al: The human cadherin 11
is a proapoptotic tumor suppressor modulating cell stemness through
Wnt/betacatenin signaling and silenced in common carcinomas.
Oncogene. 31:390139122012. View Article : Google Scholar
|
|
21
|
Booher RN, Holman PS and Fattaey A: Human
Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not
Cdk2 activity. J Biol Chem. 272:22300–22306. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu F, Stanton JJ, Wu Z and PiwnicaWorms
H: The human Myt1 kinase preferentially phosphorylates Cdc2 on
threonine 14 and localizes to the endoplasmic reticulum and Golgi
complex. Mol Cell Biol. 17:5715831997. View Article : Google Scholar
|
|
23
|
Parker LL and Piwnica-Worms H:
Inactivation of the p34cdc2-cyclin B complex by the human WEE1
tyrosine kinase. Science. 257:195519571992. View Article : Google Scholar
|
|
24
|
Raff MC, Barres BA, Burne JF, Coles HS,
Ishizaki Y and Jacobson MD: Programmed cell death and the control
of cell survival: Lessons from the nervous system. Science.
257:1955–1957. 1992.
|
